The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions
- 23 August 2007
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (12) , 2088-2095
- https://doi.org/10.1007/s00259-007-0562-7
Abstract
The aim of this study was to evaluate retrospectively the efficacy of whole-body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for autoimmune pancreatitis (AIP) and associated extrapancreatic autoimmune lesions.Keywords
This publication has 23 references indexed in Scilit:
- FDG PET and PET/CT Monitoring of Autoimmune Pancreatitis Associated With Extrapancreatic Autoimmune DiseaseClinical Nuclear Medicine, 2007
- Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parametersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Autoimmune pancreatitis: proposal of IgG4-related sclerosing diseaseThe Esophagus, 2006
- Positron emission tomography (PET): Evaluation of chronic periaortitisArthritis Care & Research, 2005
- Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitisPancreatology, 2005
- Morphological changes after steroid therapy in autoimmune pancreatitisScandinavian Journal of Gastroenterology, 2004
- High Serum IgG4 Concentrations in Patients with Sclerosing PancreatitisNew England Journal of Medicine, 2001
- Exact and approximate rebinning algorithms for 3-D PET dataIEEE Transactions on Medical Imaging, 1997
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Chronic pancreatitis caused by an autoimmune abnormalityDigestive Diseases and Sciences, 1995